Proprietary Manufacturing
Optimizing the means of cell production
Manufacturing therapeutic proteins and viral vectors for gene therapy can be costly, time-intensive, and complex. Our proprietary protein manufacturing platform aims to address these challenges.
Our potentially ground-breaking technique seeks to reduce the complexity and cost of current cell production approaches by taking advantage of the unique properties of algae. With this platform, we are exploring how to deliver rapid scalability, no plasmid transfection, low production costs, and ease of culturing and maintenance.
Learn how we aim to address the cost and complexity of cell production by harnessing the unique properties of algae.
Your Privacy Choices